The Future of Medicine

Developing New Categories of Medicine

Our goal is to improve and extend the lives of patients through the development of breakthrough medicine

Exploring the Brain Immune Gut (BIG) Axis

PureTech Health is pioneering the development of therapeutics based on the crosstalk and biology of the Brain-Immune-Gut Axis

Giving Life to Science

Our goal is to improve and extend the lives of patients

The biopharma company of the future

Discovery Reinvented

Publications
Publications -2018-03-23
PureTech's Lymphatic Leap
Publications -2017-09-19
Gamma Delta T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation

CD4(+) T regulatory cells (T(regs)), which express the Foxp3 transcription factor, play a critical role in the maintenance of immune homeostasis. Here, we show that in mice, T(regs) were most abundant in the colonic mucosa.

Full Article

Publications -2017-09-19
The Gut’s Clostridium Cocktail
Press releases
2018-10-16
PureTech’s Independent Affiliate resTORbio Announces Additional RTB101 Phase 2b Data Confirming and Expanding Upon Previously Announced Results

Continue

Press releases
2018-10-15
PureTech’s Karuna Announces Initiation of Phase 2 Study with Proprietary Lead Product Candidate KarXT for the Treatment of Schizophrenia

Continue

Press releases
2018-10-04
PureTech’s Vedanta Biosciences Announces Successful Phase 1a/1b Demonstrating Safety, Tolerability, and Proof of Mechanism for Lead Product Candidate, VE303

Continue